Treatment of skeletal disease in breast cancer with clodronate
- 31 December 1991
- Vol. 12, S25-S30
- https://doi.org/10.1016/8756-3282(91)90063-o
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Treatment of painful bone lesions and hypercalcemiaEuropean Journal of Haematology, 1989
- Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissuesJournal of the Autonomic Nervous System, 1988
- Substance P- and CGRP-immunoreactive nerves in bonePeptides, 1988
- Clodronate. A randomized study in the treatment of cancer-related hypercalcemiaArchives of internal medicine (1960), 1987
- The hypercalcemia of malignancyKidney International, 1987
- Stimulation of Bone Resorption in Vitro by Synthetic Transforming Growth Factor-AlphaScience, 1985
- Intravenous etidronate in the management of malignant hypercalcemiaArchives of internal medicine (1960), 1985
- The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myelomaBritish Journal of Haematology, 1983
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- Cancer of the BreastNew England Journal of Medicine, 1980